Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67

Desser et al determine if there's a societal preference for prioritizing the treatment of rare diseases that could justify ignoring cost effectiveness thresholds for orphan drugs. Results show that there is little evidence that a societal preference for rarity in itself exists. Orphan drugs--th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BMJ 2010, Vol.341 (7774), p.c5396
Hauptverfasser:	Desser, Arna S, Gyrd-Hansen, Dorte, Olsen, Jan Abel, Grepperud, Sverre, Kristiansen, Ivar Sønbø
Format:	Artikel
Sprache:	eng
Schlagworte:	Disease Drugs Medical treatment R&D Research & development Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!